Status:
COMPLETED
Extension Study Of Subjects From Study A3921030 For The Prevention Of Acute Rejection In Kidney Transplant Patients
Lead Sponsor:
Pfizer
Conditions:
Kidney Transplantation
Eligibility:
All Genders
18-70 years
Phase:
PHASE2
Brief Summary
This is a study that will follow transplant patients from Study A3921030 to monitor for long term safety, tolerability and efficacy for 5 additional years, except in Portugal where the study will foll...
Eligibility Criteria
Inclusion
- Subjects who successfully completed Study A3921030
Exclusion
- Subjects who are on the waiting list for a second kidney transplant or any non-renal organ transplants
Key Trial Info
Start Date :
August 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2015
Estimated Enrollment :
178 Patients enrolled
Trial Details
Trial ID
NCT00658359
Start Date
August 1 2008
End Date
June 1 2015
Last Update
February 23 2018
Active Locations (65)
Enter a location and click search to find clinical trials sorted by distance.
1
Cedars-Sinai Medical Center
Los Angeles, California, United States, 90048
2
Cedars-Sinai MedicalCenter
Los Angeles, California, United States, 90048
3
Ronald Reagan UCLA Medical Center
Los Angeles, California, United States, 90095
4
UCLA Medical Center
Los Angeles, California, United States, 90095